MAKO Medical Expands Popular ASPT-Accredited Phlebotomy Program

Nashville, TN, December 31, 2022 –(– MAKO Medical Laboratories, a national full-service reference laboratory and national leader in COVID-19 testing, is expanding its accredited American Society of Phlebotomy Technicians (ASPT) training school for phlebotomists by adding additional training dates and options for classes, as well as a full-time class. Currently, the classes are for MAKO Medical employees, but the facility plans to offer the training to those outside of MAKO in early 2023.

“We care deeply about the needs and wants of our team, and we are excited to be able to offer phlebotomy certifications as yet another career growth opportunity within MAKO,” said Josh Arant, Chief Operating Officer, MAKO Medical.

MAKO team members can sign up for the Phlebotomy course through MAKO University (MAKO U), a career enhancement effort established during this rapidly changing time in health care. MAKO will offer this program at no charge to team members across all MAKO locations.

Says Chad Price, MAKO Medical Founder and CEO, “We’re pleased by the success of our phlebotomist training program and are excited to be expanding the school.”

MAKO U has the backing of ASPT, one of the top two phlebotomy certifiers in the U.S. It will include 14 weeks of class time and hands-on instruction, with the potential for expediting the process, depending on how quickly students progress through hands-on clinical days.

“Without a certification, phlebotomists are hard-pressed to land a job,” said Tiffany Filbeck, MAKO phlebotomy supervisor and lead instructor for MAKO U. “I’m looking forward to pursuing my passion of teaching while making a lasting impact on students’ career trajectories beyond their certification exam.”

In order to pass the program and qualify for the ASPT certification exam, MAKO U students will participate in two four-hour virtual instruction days per week, paired with online assignments. One month into the program, students will begin hands-on training by practicing on manikin arms before moving to the real thing.

Students will need to conduct 25 successful draws before progressing to their clinical rotation where they must complete an additional 75 successful draws before then taking the ASPT exam for final certification. The exam includes a written portion and a practical blood draw simulation.

As MAKO team members graduate MAKO U and receive their certification, they will be able to return to assist with future classes as instructors. This keeps them involved in the program while also allowing them to stay up-to-date on their skills. As more graduates return to serve as instructors, MAKO hopes to increase teaching capacity enough to open the program up to the public.

About MAKO Medical
Founded in 2014 by Chad Price, MAKO Medical is a College of American Pathologists (CAP)-accredited laboratory that operates more than 85,000 square feet of laboratory space across three laboratory facilities along the East Coast of the United States. In total, MAKO has capacity to process over 200,000 tests per day.

Since April 2020, Chad Price and MAKO Medical have processed more than 13 million COVID-19 tests utilizing RT-PCR technology and industry-leading testing assays, including the Applied Biosystems TaqPath COVID-19 Combo Assay. The MAKO team also partnered with the CDC to provide next-generation sequencing of SARS-CoV-2 during the height of the pandemic.

MAKO’s core business is setting a higher standard by serving as a diagnostics partner for healthcare providers across the United States. The MAKO Way delivers turnkey lab services with precision and accuracy.

Company Highlights:

● August 2022, Inc. magazine recognized MAKO Medical as one of America’s Fastest Growing Private Companies. This is the second time the publication has recognized MAKO in recent years.
● March 2022, Forbes recognized MAKO Medical as one of America’s Best Startup Employers.
● May 2021, the Triangle Business Journal recognized MAKO Medical with a 2021 Life Sciences Award.
● August 2020, MAKO Medical announced the company scored 100% on CAP COVID Proficiency Testing, demonstrating MAKO’s commitment to quality lab results.

Source link

Leave a Replay

About VujaDE

Venture Capital fund focused on resolving global problems through innovative technologies, we invest in AGTech, DeepTech, LegalTech and HealthTech.

Recent Posts

Get in to the inner circle

Join our online realtime community at Discord

Meet Founders, Limited Partners, and the VujaDE Team. Get access to great industry knowhow from experts and more…